Oncologic Drugs Advisory Committee
GPTKB entity
Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:abbreviation |
gptkb:ODAC
|
| gptkbp:advisorTo |
Center for Drug Evaluation and Research
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:domain |
oncology
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oncologic Drugs Advisory Committee
|
| gptkbp:partOf |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:purpose |
advises FDA on cancer drug approvals
|
| gptkbp:reviewedBy |
biologics for cancer
new cancer drugs |
| gptkbp:type |
federal advisory committee
|
| gptkbp:website |
https://www.fda.gov/advisory-committees/oncologic-drugs-advisory-committee
|
| gptkbp:bfsParent |
gptkb:ODAC
|
| gptkbp:bfsLayer |
6
|